可手术切除胰腺腺癌患者术前CT:CT与手术间的时间间隔是否影响生存
单中心回顾性分析2010年1月1日至2015年12月31日间尝试切除胰腺腺癌或壶腹部周围腺癌的239例患者,均行术前腹部CT,按影像-手术间隔(ISI)≥/<25天分组。ISI较长者术中意外进展比例更高(中位46天 vs 29天,p<0.05);意向性治疗分析中ISI≥/<25天总生存无差异;胰腺腺癌切除者ISI不影响无病生存或总生存;壶腹部周围腺癌切除者ISI≥25天与更长总生存相关(p<0.05),回归分析中较长ISI独立关联总生存改善。结论:可切除胰腺腺癌在CT后25天内手术可减少意外进展但不带来生存获益;壶腹部周围腺癌切除者较长ISI与更长总生存相关,可能反映该队列中生物学行为更惰性的疾病。
要点
- 意外进展患者术前CT至手术间隔更长(中位46天 vs 29天,p<0.05)。
- 意向性治疗分析中ISI≥/<25天总生存无差异。
- 壶腹部周围腺癌切除者ISI≥25天与更长总生存相关(p<0.05),无病生存不受影响。
核心结论
- 可切除胰腺腺癌在腹部CT后25天内手术可减少术中意外进展,但未带来生存获益。
- 壶腹部周围腺癌切除者较长ISI与更长总生存相关,可能反映该队列中生物学行为更惰性的疾病。
- 胰腺腺癌切除者中ISI不影响无病生存或总生存。
研究设计与样本
- 单中心、经伦理委员会批准的回顾性分析,纳入2010年1月1日至2015年12月31日间尝试切除胰腺腺癌或壶腹部周围腺癌的全部患者。
- 所有患者行术前腹部CT;排除临界可切除病变及接受新辅助化疗/放疗者;随访至2016年6月30日。
- 共239例患者接受手术探查;按ISI≥/<25天分组,行Kaplan-Meier及Cox回归生存分析。
诊断标准与关键数值
- 意外进展见于29例(12.1%),其ISI中位46天 vs 无意外进展者29天(p<0.05)。
- 意向性治疗分析中ISI≥/<25天总生存无差异。
- 胰腺腺癌切除者(n=174)ISI不影响无病生存或总生存。
- 壶腹部周围腺癌切除者(n=36)ISI≥25天与更长总生存相关(p<0.05),无病生存不受影响;回归分析中较长ISI独立关联总生存改善。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The preoperative imaging-to-surgery time interval (ISI) influences the risk of unexpected progression (UP) found at surgery for pancreatic adenocarcinoma. We aimed to assess whether ISI influences disease recurrence and/or survival.
METHODS AND MATERIALS: A single-institution, ethics board-approved retrospective analysis of all patients who underwent attempted resection of pancreatic (PDAC) or periampullary adenocarcinoma (AmpAC) between 1st January 2010 and 31st December 2015 was performed. All patients underwent preoperative abdominal computed tomography (CT). Exclusion criteria were borderline resectable disease and neoadjuvant chemo/radiotherapy. Patients were followed up until 30th June 2016. The population was divided into ISI ≥/<25 days. Kaplan-Meier and Cox regression survival analyses were performed.
RESULTS: 239 patients underwent surgical exploration. UP was found in 29 (12.1%) and these patients had longer ISI (median 46 vs. 29 days, p < 0.05). When intention-to-treat analysis was performed, there was no difference in overall survival (OS) between patients with ISI ≥/<25. In those who underwent resection, ISI did not influence disease-free survival (DFS) or OS for PDAC (n = 174). For AmpAC (n = 36), ISI ≥ 25 days was associated with longer OS (p < 0.05) but did not influence DFS. Longer ISI was independently associated with improved OS on regression analysis for AmpAC.
CONCLUSION: Performing surgery for resectable pancreatic adenocarcinoma within 25 days of abdominal CT reduces the chance of UP but does not confer a survival benefit. For those who undergo resection of AmpAC, a longer ISI was associated with longer OS. This probably represents a more biologically indolent disease in this cohort.
引用
- Healy GM, Redmond CE, Murphy S, et al. Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival? Abdom Radiol (NY). 2018. PMID: 28695235. doi:10.1007/s00261-017-1254-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。